The Role of Simulation Science in Public Health at the Agency for Toxic Substances and Disease Registry: An Overview and Analysis of the Last Decade

The Role of Simulation Science in Public Health at the Agency for Toxic Substances and Disease Registry: An Overview and Analysis of the Last Decade

Environmental exposures are ubiquitous and play a significant, and sometimes understated, role in public health as they can lead to the development of various chronic and infectious diseases. In an ideal world, there would be sufficient experimental data to determine the health effects of exposure t...

Full description

Saved in:

Bibliographic Details
Main Authors:	Siddhi Desai, Jewell Wilson, Chao Ji, Jason Sautner, Andrew J. Prussia, Eugene Demchuk, M. Moiz Mumtaz, Patricia Ruiz
Format:	Article
Language:	English
Published:	MDPI AG 2024-11-01
Series:	Toxics
Subjects:	computational toxicology PBPK QSAR BMD fate and transport modeling machine learning modeling
Online Access:	https://www.mdpi.com/2305-6304/12/11/811
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Novel Machine Learning Model and a Web Portal for Predicting the Human Skin Sensitization Effects of Chemical Agents
by: Ricardo Scheufen Tieghi, et al.
Published: (2024-11-01)

Statement concerning the review of the approval of the basic substances chitosan and chitosan hydrochloride when used in plant protection
by: EFSA Panel on Plant Protection Products and their Residues (PPR), et al.
Published: (2025-04-01)

A systematic review of computational simulation methods for predicting the toxicity of chemical compounds
by: Akram Tabrizi, et al.
Published: (2025-07-01)

Overview of Computational Toxicology Methods Applied in Drug and Green Chemical Discovery
by: Jose I. Bueso-Bordils, et al.
Published: (2024-12-01)

Binding of per- and polyfluoroalkyl substances with liver and serum proteins in rats: implications for physiologically based pharmacokinetic modelling
by: Xiarui Fan, et al.
Published: (2025-07-01)

Approaches to conducting a physiologically relevant test (PRT) in the study of medicines containing substance IIc of the BCS subclass using sorafenib as an example
by: A. V. Suvorova, et al.
Published: (2024-09-01)

PBPK Modeling of Acetaminophen in Pediatric Populations: Incorporation of SULT Enzyme Ontogeny to Predict Age-Dependent Metabolism and Systemic Exposure
by: Sonia Sharma, et al.
Published: (2025-07-01)

Using the Simcyp R Package for PBPK Simulation Workflows With the Simcyp Simulator
by: Anthonia M. Onasanwo, et al.
Published: (2025-05-01)

Physiologically based pharmacokinetic modeling supports investigation of potential drug-drug interactions in the pre- and early post-hematopoietic stem cell transplantation stages
by: Peile Wang, et al.
Published: (2025-05-01)

PRT to predict pharmacokinetic profiles as part of a bioequivalence study of the drug deferasirox
by: A. V. Suvorova, et al.
Published: (2024-09-01)

A PBPK modeling approach for personalized dose optimization of nicardipine in renal and hepatic dysfunction
by: Ammara Ayub, et al.
Published: (2025-06-01)

Utilizing Physiologically Based Pharmacokinetic Models to Support Rational Medication in Chinese Elderly Population
by: Wu X, et al.
Published: (2025-04-01)

Improving Individualized Salbutamol Treatment: A Population Pharmacokinetic Model for Oral Salbutamol in Virtual Patients
by: Lara Marques, et al.
Published: (2024-12-01)

AI Methods for New Psychoactive Substance (NPS) Design and Analysis
by: Enrico Greco
Published: (2025-04-01)

Assessing the Application of Physiologically Based Pharmacokinetic Models in Acute Chemical Incidents
by: Sydney Boone, et al.
Published: (2025-03-01)

Investigation of Antibody Pharmacokinetics in Male Reproductive System and Its Characterization Using a Translational PBPK Model
by: Sree Ojili, et al.
Published: (2025-02-01)

Facioscapulohumeral muscular dystrophy type 1 combined with becker muscular dystrophy: a family case report
by: Menglin Tan, et al.
Published: (2025-01-01)

Evaluation of bone health problems among a group of children with rheumatological diseases
by: Hala Lotfy, et al.
Published: (2024-12-01)

QSAR Models for Predicting the Antioxidant Potential of Chemical Substances
by: Sofia Ghironi, et al.
Published: (2025-05-01)

The Role of Pharmacometrics in Advancing the Therapies for Autoimmune Diseases
by: Artur Świerczek, et al.
Published: (2024-12-01)

Prediction of Monoclonal Antibody Pharmacokinetics in Pediatric Populations Using PBPK Modeling and Simulation
by: Chiara Zunino, et al.
Published: (2025-07-01)

Accuracy and precision analyses of single-time-point dosimetry utilising physiologically-based pharmacokinetic modelling and non-linear mixed-effects modelling
by: Indra Budiansah, et al.
Published: (2025-03-01)

Screening benzimidazole derivatives for atypical antipsychotic activity
by: K. Yu. Kalitin, et al.
Published: (2025-08-01)

Perfluoroalkyl and polyfluoroalkyl substances in sewage sludge: challenges of biological and thermal treatment processes and potential threats to the environment from land disposal
by: Olga S. Arvaniti, et al.
Published: (2024-12-01)

UJI AKTIVITAS ANTIOKSIDAN PADA MODIFIKASI SENYAWA KHRISIN DENGAN GUGUS ALKOKSI MENGGUNAKAN METODE RECIFE MODEL 1 (RM1)
by: FK Nisa, et al.
Published: (2016-04-01)

Tissue-resident memory CD4+ T cells are sustained by site-specific levels of self-renewal and continuous replacement
by: Jodie Chandler, et al.
Published: (2025-06-01)

Removal and prediction of chemicals in anaerobic–anoxic–aerobic wastewater treatment system: Case study on organophosphates
by: Linjun Zhou, et al.
Published: (2024-12-01)

Mechanistic Insights into Cytokine Antagonist-Drug Interactions: A Physiologically Based Pharmacokinetic Modelling Approach with Tocilizumab as a Case Study
by: Xian Pan, et al.
Published: (2025-07-01)

Personalized metronomic radiopharmaceutical therapy through injection profile optimization via physiologically based pharmacokinetic (PBPK) modeling
by: Aryan Golzaryan, et al.
Published: (2025-02-01)

Pyridoxic Acid as Endogenous Biomarker of Renal Organic Anion Transporter Activity: Population Variability and Mechanistic Modeling to Predict Drug–Drug Interactions
by: Aarzoo Thakur, et al.
Published: (2025-05-01)

Development and Application of Physiologically-Based Pharmacokinetic Model to Predict Systemic and Organ Exposure of Colorectal Cancer Drugs
by: Sara Peribañez-Dominguez, et al.
Published: (2025-01-01)

Combining fugacity and physiologically based toxicokinetic concepts in a mechanistic model describing the fate of lipophilic contaminants in lactating cows
by: Sylvain Lerch, et al.
Published: (2025-05-01)

Advancements in Virtual Bioequivalence: A Systematic Review of Computational Methods and Regulatory Perspectives in the Pharmaceutical Industry
by: Nasser Alotaiq, et al.
Published: (2024-11-01)

Evaluation of Drug–Drug Interactions Between Clarithromycin and Direct Oral Anticoagulants Using Physiologically Based Pharmacokinetic Models
by: Zhuan Yang, et al.
Published: (2024-11-01)

Model-Informed Dose Optimization of Spironolactone in Neonates and Infants
by: Amira Soliman, et al.
Published: (2025-03-01)

Precision Medicine in Oncology: Imatinib Dosing in the Obese Cancer Population Using Virtual Clinical Trials
by: Khairulanwar Burhanuddin, et al.
Published: (2025-06-01)

Exploring the Feasibility of a Bracketing Approach Utilizing Modeling for Development of Long-Acting Injectables for Regulatory Approval—A Case Study Using Levonorgestrel
by: Susan Cole, et al.
Published: (2024-12-01)

Model-Based Dose Selection of a Sphingosine-1-Phosphate Modulator, Etrasimod, in Patients with Various Degrees of Hepatic Impairment
by: Mohammed S. Alasmari, et al.
Published: (2024-12-01)

Genotype, Ethnicity, and Drug–Drug Interaction Modeling as Means of Verifying Transporter Biomarker PBPK Model: The Coproporphyrin‐I Story
by: Yuki Ujihira, et al.
Published: (2025-05-01)

Py-CoMSIA: An Open-Source Implementation of Comparative Molecular Similarity Indices Analysis in Python
by: Christopher L. Haga, et al.
Published: (2025-03-01)